Circular Genomics is a biotechnology and genomics company that develops RNA-based diagnostics for neurological diseases.
Circular Genomics has raised $8.3M in total funding. The most recent round was Series A. The last funding was announced in January 2024.
Circular Genomics's investors include Cottonwood Technology Fund, New Mexico Economic Development Department, Mountain Group Capital, Tramway Venture Partners, UNM Rainforest Innovations.
Circular Genomics is headquartered in Albuquerque, United States.
Circular Genomics is a biotechnology and genomics company that develops RNA-based diagnostics for neurological diseases.
Circular Genomics is at the Series A stage.
Free to use in articles, research, and reference works. Stable URL — will not change. Data on this page last updated .
"Circular Genomics — Funding & Investors." VCBacked, January 23, 2024, https://www.vcbacked.co/company/circular-genomics. Accessed September 15, 2026.
VCBacked. (2024). Circular Genomics — Funding & Investors. Retrieved September 15, 2026, from https://www.vcbacked.co/company/circular-genomics
{{cite web |title=Circular Genomics — Funding & Investors |url=https://www.vcbacked.co/company/circular-genomics |website=VCBacked |access-date=September 15, 2026}}Profile data sourced and verified per the VCbacked methodology · Last funding round dated